25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

VANI (Vivani) Stock Analysis
Buy, Hold or Sell?

Let's analyze Vivani together

I guess you are interested in Vivani Medical Inc.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Vivani’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Vivani’s Price Targets

I'm going to help you getting a better view of Vivani Medical Inc.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Vivani Medical Inc.

I send you an email if I find something interesting about Vivani Medical Inc..

1. Quick Overview

1.1. Quick analysis of Vivani (30 sec.)










1.2. What can you expect buying and holding a share of Vivani? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.30
Expected worth in 1 year
$0.24
How sure are you?
22.5%

+ What do you gain per year?

Total Gains per Share
$-0.05
Return On Investment
-5.2%

For what price can you sell your share?

Current Price per Share
$1.03
Expected price per share
$0.85 - $1.12
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Vivani (5 min.)




Live pricePrice per Share (EOD)
$1.03
Intrinsic Value Per Share
$-5.11 - $-4.55
Total Value Per Share
$-4.81 - $-4.25

2.2. Growth of Vivani (5 min.)




Is Vivani growing?

Current yearPrevious yearGrowGrow %
How rich?$17.6m$29.4m-$7.3m-33.1%

How much money is Vivani making?

Current yearPrevious yearGrowGrow %
Making money-$5.8m-$6.3m$470.7k8.0%
Net Profit Margin-760.1%-290.8%--

How much money comes from the company's main activities?

2.3. Financial Health of Vivani (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Vivani?

Welcome investor! Vivani's management wants to use your money to grow the business. In return you get a share of Vivani.

First you should know what it really means to hold a share of Vivani. And how you can make/lose money.

Speculation

The Price per Share of Vivani is $1.03. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Vivani.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Vivani, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.30. Based on the TTM, the Book Value Change Per Share is $-0.01 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.10 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Vivani.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.10-9.9%-0.10-9.6%-0.11-10.5%-0.08-7.4%-0.10-9.8%
Usd Book Value Change Per Share-0.01-1.2%-0.01-1.3%-0.10-9.6%0.010.8%-0.01-0.7%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.01-1.2%-0.01-1.3%-0.10-9.6%0.010.8%-0.01-0.7%
Usd Price Per Share1.16-1.36-1.06-1.95-2.66-
Price to Earnings Ratio-2.84--3.43--2.46--6.94--7.71-
Price-to-Total Gains Ratio-95.18--27.32--10.71--18.81--33.27-
Price to Book Ratio3.90-3.66-2.24--4.58-4.32-
Price-to-Total Gains Ratio-95.18--27.32--10.71--18.81--33.27-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.03
Number of shares970
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.010.01
Usd Total Gains Per Share-0.010.01
Gains per Quarter (970 shares)-12.908.46
Gains per Year (970 shares)-51.5933.84
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-52-6203424
20-103-11406858
30-155-166010292
40-206-2180135126
50-258-2700169160
60-310-3220203194
70-361-3740237228
80-413-4260271262
90-464-4780305296
100-516-5300338330

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%1.011.00.08.3%1.019.00.05.0%1.039.00.02.5%1.047.00.02.1%
Book Value Change Per Share1.03.00.025.0%2.010.00.016.7%5.015.00.025.0%9.031.00.022.5%10.035.03.020.8%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.048.00.0%
Total Gains per Share1.03.00.025.0%2.010.00.016.7%5.015.00.025.0%9.031.00.022.5%10.035.03.020.8%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Vivani Medical Inc. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.012-0.013+9%-0.099+715%0.009-240%-0.007-41%
Book Value Per Share--0.2970.373-20%0.497-40%0.390-24%0.335-11%
Current Ratio--3.4154.128-17%5.052-32%5.320-36%4.252-20%
Debt To Asset Ratio--0.5760.530+9%0.413+40%0.584-1%0.475+21%
Debt To Equity Ratio--1.3601.149+18%0.811+68%0.829+64%0.785+73%
Dividend Per Share----0%-0%-0%-0%
Enterprise Value--63122764.00079213344.000-20%70560831.250-11%127999568.565-51%168056606.135-62%
Eps---0.102-0.099-3%-0.108+6%-0.076-26%-0.101-1%
Ev To Ebitda Ratio---2.477-3.275+32%-2.644+7%-9.598+287%-9.274+274%
Ev To Sales Ratio--79.300infnan%infnan%infnan%infnan%
Free Cash Flow Per Share---0.103-0.090-13%-0.104+1%-0.079-23%-0.094-9%
Free Cash Flow To Equity Per Share---0.022-0.010-55%-0.103+378%0.056-139%0.018-220%
Gross Profit Margin--1.0161.005+1%1.004+1%1.0210%1.167-13%
Intrinsic Value_10Y_max---4.548--------
Intrinsic Value_10Y_min---5.107--------
Intrinsic Value_1Y_max---0.380--------
Intrinsic Value_1Y_min---0.402--------
Intrinsic Value_3Y_max---1.198--------
Intrinsic Value_3Y_min---1.310--------
Intrinsic Value_5Y_max---2.087--------
Intrinsic Value_5Y_min---2.323--------
Market Cap61020187.000-13%68721764.00080570344.000-15%62945581.250+9%115514768.565-41%157372839.560-56%
Net Profit Margin---30.402-7.601-75%-2.908-90%-698.256+2197%-352.422+1059%
Operating Margin---32.462-8.116-75%-3.000-91%-684.531+2009%-345.559+964%
Operating Ratio--33.4628.366+300%3.000+1015%684.606-95%346.035-90%
Pb Ratio3.465-13%3.9023.659+7%2.243+74%-4.582+217%4.323-10%
Pe Ratio-2.521+11%-2.840-3.432+21%-2.456-14%-6.938+144%-7.706+171%
Price Per Share1.030-13%1.1601.360-15%1.063+9%1.950-41%2.656-56%
Price To Free Cash Flow Ratio-2.498+11%-2.813-3.887+38%-2.710-4%-9.122+224%-8.926+217%
Price To Total Gains Ratio-84.515+11%-95.182-27.323-71%-10.709-89%-18.806-80%-33.269-65%
Quick Ratio--3.0663.834-20%4.507-32%4.987-39%4.509-32%
Return On Assets---0.146-0.127-12%-0.126-14%-0.327+125%-0.360+147%
Return On Equity---0.344-0.277-19%-0.227-34%-0.407+19%-0.612+78%
Total Gains Per Share---0.012-0.013+9%-0.099+715%0.009-240%-0.007-41%
Usd Book Value--17610000.00022119000.000-20%29432500.000-40%23087950.000-24%19830402.250-11%
Usd Book Value Change Per Share---0.012-0.013+9%-0.099+715%0.009-240%-0.007-41%
Usd Book Value Per Share--0.2970.373-20%0.497-40%0.390-24%0.335-11%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Enterprise Value--63122764.00079213344.000-20%70560831.250-11%127999568.565-51%168056606.135-62%
Usd Eps---0.102-0.099-3%-0.108+6%-0.076-26%-0.101-1%
Usd Free Cash Flow---6108000.000-5335500.000-13%-6146500.000+1%-4691300.000-23%-5575100.000-9%
Usd Free Cash Flow Per Share---0.103-0.090-13%-0.104+1%-0.079-23%-0.094-9%
Usd Free Cash Flow To Equity Per Share---0.022-0.010-55%-0.103+378%0.056-139%0.018-220%
Usd Market Cap61020187.000-13%68721764.00080570344.000-15%62945581.250+9%115514768.565-41%157372839.560-56%
Usd Price Per Share1.030-13%1.1601.360-15%1.063+9%1.950-41%2.656-56%
Usd Profit---6050000.000-5871500.000-3%-6342250.000+5%-4134800.000-32%-5827375.000-4%
Usd Revenue--199000.00049750.000+300%129500.000+54%35863.000+455%797281.500-75%
Usd Total Gains Per Share---0.012-0.013+9%-0.099+715%0.009-240%-0.007-41%
 EOD+3 -5MRQTTM+8 -29YOY+20 -175Y+9 -2810Y+8 -29

3.3 Fundamental Score

Let's check the fundamental score of Vivani Medical Inc. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.521
Price to Book Ratio (EOD)Between0-13.465
Net Profit Margin (MRQ)Greater than0-30.402
Operating Margin (MRQ)Greater than0-32.462
Quick Ratio (MRQ)Greater than13.066
Current Ratio (MRQ)Greater than13.415
Debt to Asset Ratio (MRQ)Less than10.576
Debt to Equity Ratio (MRQ)Less than11.360
Return on Equity (MRQ)Greater than0.15-0.344
Return on Assets (MRQ)Greater than0.05-0.146
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of Vivani Medical Inc. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose1.040
Total1/1 (100.0%)

4. In-depth Analysis

4.1 About Vivani Medical Inc.

Vivani Medical, Inc., a preclinical stage biopharmaceutical company, engages in the development of miniaturized and subdermal implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease, medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatide implant candidate is in preclinical stage development for the treatment of chronic weight management in patients with obesity or overweight; NPM-119, an exenatide implant candidate is in preclinical stage development for the treatment of patients with type 2 diabetes; NPM-139, a miniature, subdermal GLP-1 implant in development for chronic weight management; and OKV-119, an exenatide implant is under development for metabolic diseases in cats including for the treatment of obesity and diabetes. The company is headquartered in Alameda, California.

Fundamental data was last updated by Penke on 2025-04-06 11:15:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Vivani earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Vivani to theΒ Biotechnology industry mean.
  • A Net Profit Margin of -3,040.2%Β means thatΒ $-30.40 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Vivani Medical Inc.:

  • The MRQ is -3,040.2%. The company is making a huge loss. -2
  • The TTM is -760.1%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-3,040.2%TTM-760.1%-2,280.2%
TTM-760.1%YOY-290.8%-469.2%
TTM-760.1%5Y-69,825.6%+69,065.5%
5Y-69,825.6%10Y-35,242.2%-34,583.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3,040.2%-100.3%-2,939.9%
TTM-760.1%-188.1%-572.0%
YOY-290.8%-200.1%-90.7%
5Y-69,825.6%-393.6%-69,432.0%
10Y-35,242.2%-501.9%-34,740.3%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Vivani is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Vivani to theΒ Biotechnology industry mean.
  • -14.6% Return on Assets means thatΒ Vivani generatedΒ $-0.15 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Vivani Medical Inc.:

  • The MRQ is -14.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -12.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-14.6%TTM-12.7%-1.8%
TTM-12.7%YOY-12.6%-0.2%
TTM-12.7%5Y-32.7%+20.0%
5Y-32.7%10Y-36.0%+3.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-14.6%-12.5%-2.1%
TTM-12.7%-12.3%-0.4%
YOY-12.6%-12.5%-0.1%
5Y-32.7%-13.8%-18.9%
10Y-36.0%-15.7%-20.3%
4.3.1.3. Return on Equity

Shows how efficient Vivani is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Vivani to theΒ Biotechnology industry mean.
  • -34.4% Return on Equity means Vivani generated $-0.34Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Vivani Medical Inc.:

  • The MRQ is -34.4%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -27.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-34.4%TTM-27.7%-6.6%
TTM-27.7%YOY-22.7%-5.0%
TTM-27.7%5Y-40.7%+13.0%
5Y-40.7%10Y-61.2%+20.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-34.4%-16.1%-18.3%
TTM-27.7%-16.2%-11.5%
YOY-22.7%-16.1%-6.6%
5Y-40.7%-21.0%-19.7%
10Y-61.2%-22.2%-39.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Vivani Medical Inc..

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Vivani is operatingΒ .

  • Measures how much profit Vivani makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Vivani to theΒ Biotechnology industry mean.
  • An Operating Margin of -3,246.2%Β means the company generated $-32.46 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Vivani Medical Inc.:

  • The MRQ is -3,246.2%. The company is operating very inefficient. -2
  • The TTM is -811.6%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-3,246.2%TTM-811.6%-2,434.7%
TTM-811.6%YOY-300.0%-511.5%
TTM-811.6%5Y-68,453.1%+67,641.5%
5Y-68,453.1%10Y-34,555.9%-33,897.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3,246.2%-193.7%-3,052.5%
TTM-811.6%-286.4%-525.2%
YOY-300.0%-223.4%-76.6%
5Y-68,453.1%-393.8%-68,059.3%
10Y-34,555.9%-475.0%-34,080.9%
4.3.2.2. Operating Ratio

Measures how efficient Vivani is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Biotechnology industry mean).
  • An Operation Ratio of 33.46 means that the operating costs are $33.46 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Vivani Medical Inc.:

  • The MRQ is 33.462. The company is inefficient in keeping operating costs low. -1
  • The TTM is 8.366. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ33.462TTM8.366+25.097
TTM8.366YOY3.000+5.365
TTM8.3665Y684.606-676.240
5Y684.60610Y346.035+338.571
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ33.4622.208+31.254
TTM8.3663.152+5.214
YOY3.0003.121-0.121
5Y684.6065.168+679.438
10Y346.0356.512+339.523
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Vivani Medical Inc..

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Vivani is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Biotechnology industry mean).
  • A Current Ratio of 3.41Β means the company has $3.41 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Vivani Medical Inc.:

  • The MRQ is 3.415. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.128. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.415TTM4.128-0.713
TTM4.128YOY5.052-0.924
TTM4.1285Y5.320-1.191
5Y5.32010Y4.252+1.068
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.4153.726-0.311
TTM4.1283.930+0.198
YOY5.0524.316+0.736
5Y5.3205.777-0.457
10Y4.2526.144-1.892
4.4.3.2. Quick Ratio

Measures if Vivani is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Vivani to theΒ Biotechnology industry mean.
  • A Quick Ratio of 3.07Β means the company can pay off $3.07 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Vivani Medical Inc.:

  • The MRQ is 3.066. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.834. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.066TTM3.834-0.769
TTM3.834YOY4.507-0.672
TTM3.8345Y4.987-1.152
5Y4.98710Y4.509+0.478
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.0662.944+0.122
TTM3.8343.417+0.417
YOY4.5074.212+0.295
5Y4.9875.714-0.727
10Y4.5096.434-1.925
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Vivani Medical Inc..

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of VivaniΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Vivani to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.58Β means that Vivani assets areΒ financed with 57.6% credit (debt) and the remaining percentage (100% - 57.6%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Vivani Medical Inc.:

  • The MRQ is 0.576. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.530. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.576TTM0.530+0.046
TTM0.530YOY0.413+0.118
TTM0.5305Y0.584-0.053
5Y0.58410Y0.475+0.109
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5760.342+0.234
TTM0.5300.343+0.187
YOY0.4130.330+0.083
5Y0.5840.362+0.222
10Y0.4750.387+0.088
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Vivani is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Vivani to theΒ Biotechnology industry mean.
  • A Debt to Equity ratio of 136.0% means that company has $1.36 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Vivani Medical Inc.:

  • The MRQ is 1.360. The company is able to pay all its debts with equity. +1
  • The TTM is 1.149. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.360TTM1.149+0.211
TTM1.149YOY0.811+0.339
TTM1.1495Y0.829+0.321
5Y0.82910Y0.785+0.044
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3600.402+0.958
TTM1.1490.421+0.728
YOY0.8110.396+0.415
5Y0.8290.446+0.383
10Y0.7850.486+0.299
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Vivani generates.

  • Above 15 is considered overpriced butΒ always compareΒ Vivani to theΒ Biotechnology industry mean.
  • A PE ratio of -2.84 means the investor is paying $-2.84Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Vivani Medical Inc.:

  • The EOD is -2.521. Based on the earnings, the company is expensive. -2
  • The MRQ is -2.840. Based on the earnings, the company is expensive. -2
  • The TTM is -3.432. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.521MRQ-2.840+0.318
MRQ-2.840TTM-3.432+0.593
TTM-3.432YOY-2.456-0.976
TTM-3.4325Y-6.938+3.506
5Y-6.93810Y-7.706+0.768
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.521-1.758-0.763
MRQ-2.840-2.592-0.248
TTM-3.432-3.216-0.216
YOY-2.456-3.278+0.822
5Y-6.938-6.457-0.481
10Y-7.706-7.176-0.530
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Vivani Medical Inc.:

  • The EOD is -2.498. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -2.813. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -3.887. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.498MRQ-2.813+0.315
MRQ-2.813TTM-3.887+1.074
TTM-3.887YOY-2.710-1.176
TTM-3.8875Y-9.122+5.236
5Y-9.12210Y-8.926-0.196
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.498-2.331-0.167
MRQ-2.813-3.585+0.772
TTM-3.887-4.034+0.147
YOY-2.710-4.487+1.777
5Y-9.122-8.803-0.319
10Y-8.926-9.972+1.046
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Vivani is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Biotechnology industry mean).
  • A PB ratio of 3.90 means the investor is paying $3.90Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Vivani Medical Inc.:

  • The EOD is 3.465. Based on the equity, the company is fair priced.
  • The MRQ is 3.902. Based on the equity, the company is fair priced.
  • The TTM is 3.659. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD3.465MRQ3.902-0.437
MRQ3.902TTM3.659+0.244
TTM3.659YOY2.243+1.415
TTM3.6595Y-4.582+8.241
5Y-4.58210Y4.323-8.905
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD3.4651.585+1.880
MRQ3.9022.265+1.637
TTM3.6592.441+1.218
YOY2.2432.512-0.269
5Y-4.5823.773-8.355
10Y4.3234.294+0.029
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Vivani Medical Inc..

4.8.1. Institutions holding Vivani Medical Inc.

Institutions are holding 8.406% of the shares of Vivani Medical Inc..

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-12-31Sabby Management LLC2.2141.9781311439-816603-38.3734
2024-12-31Tanager Wealth Management LLP2.06610.18421223823-79177-6.0765
2024-12-31Vanguard Group Inc1.6332096739800
2024-12-31Geode Capital Management, LLC0.5861034715242611.2427
2024-12-31Commonwealth Equity Services Inc0.5580.000633053000
2024-12-31Monetary Management Group Inc0.32750.058519397700
2024-12-31State Street Corp0.2174012879500
2024-12-31EVOKE WEALTH, LLC0.16860.00329987000
2024-12-31Northern Trust Corp0.12140719151154019.1139
2024-12-31BlackRock Inc0.1193070692-275-0.3875
2024-12-31Jane Street Group LLC0.0965057159571590
2024-12-31WEALTHEDGE INVESTMENT ADVISORS, LLC0.06230.019336901369010
2024-12-31Charles Schwab Investment Management Inc0.050703001600
2024-12-31UBS Group AG0.031801881818813376260
2024-12-31Connective Capital Management LLC0.03050.024418088180880
2024-12-31Susquehanna International Group, LLP0.0293017333731172.9495
2024-12-31HRT FINANCIAL LLC0.02450.000114502145020
2024-12-31TWO SIGMA SECURITIES, LLC0.01940.001811503-44622-79.5047
2024-12-31Citadel Advisors Llc0.018401092210914136425
2024-12-31SBI Securities Co Ltd0.00340.0001203320330
Total 8.37842.27024962866-759155-15.3%

4.9.2. Funds holding Vivani Medical Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-02-28Vanguard Total Stock Mkt Idx Inv1.0749063670200
2025-02-28Vanguard Institutional Extnd Mkt Idx Tr0.53080.000331441700
2025-01-31Fidelity Extended Market Index0.28780.0005170478-2590-1.4965
2025-01-31Fidelity Total Market Index0.08720.000151642-145-0.28
2025-02-28iShares Micro-Cap ETF0.08040.0064764900
2025-01-31Fidelity Nasdaq Composite Index0.06860.00034065200
2025-01-31Fidelity Series Total Market Index0.06740.00013994900
2024-12-31Northern Trust Extended Eq Market Idx0.06430.0005380951154043.457
2024-12-31NT Ext Equity Mkt Idx Fd - L0.06430.0005380951154043.457
2024-12-31NT Ext Equity Mkt Idx Fd - NL0.0540.00063196900
2025-02-28Schwab Total Stock Market Index0.05070.00013001600
2024-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.04280.000625339-419-1.6267
2025-01-31Spartan Extended Market Index Pool E0.04070.000424100259012.0409
2025-01-31Spartan Total Market Index Pool E0.0340.0001201221450.7258
2025-02-28Vanguard U.S. Eq Idx Β£ Acc0.02750.00011627900
2024-12-31Extended Equity Market Fund K0.02020.000111953-165-1.3616
2024-12-31NT Ext Eq Mkt Indx Fd DC Lend T30.01530.0005907790770
2024-12-31NT Ext Eq Mkt Indx Fd DC Lend T40.01530.0005907790770
2025-02-28State St US Extended Mkt Indx NL Cl C0.01190.0004706300
2024-06-30SSgA U.S. Total Market Index Strategy0.01040.0001613758882364.6586
Total 2.64850.01181568811+46538+3.0%

5.3. Insider Transactions

Insiders are holding 48.972% of the shares of Vivani Medical Inc..

DateOwnerTypeAmountPricePost Transaction AmountLink
2025-04-02Gregg WilliamsBUY20001.01
2025-04-01Donald DwyerBUY40001.02
2025-02-28Donald DwyerBUY10001.11
2024-11-08Gregg WilliamsBUY39682531.26
2024-10-03Donald DwyerBUY5001.13
2024-10-01Donald DwyerBUY10001.14
2024-07-30Donald DwyerBUY50001.24
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2024-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets41,561
Total Liabilities23,951
Total Stockholder Equity17,610
 As reported
Total Liabilities 23,951
Total Stockholder Equity+ 17,610
Total Assets = 41,561

Assets

Total Assets41,561
Total Current Assets20,442
Long-term Assets21,119
Total Current Assets
Cash And Cash Equivalents 18,352
Other Current Assets 2,090
Total Current Assets  (as reported)20,442
Total Current Assets  (calculated)20,442
+/-0
Long-term Assets
Property Plant Equipment 19,650
Long-term Assets Other 1,469
Long-term Assets  (as reported)21,119
Long-term Assets  (calculated)21,119
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities5,986
Long-term Liabilities17,965
Total Stockholder Equity17,610
Total Current Liabilities
Short-term Debt 1,348
Accounts payable 817
Other Current Liabilities 3,821
Total Current Liabilities  (as reported)5,986
Total Current Liabilities  (calculated)5,986
+/-0
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt17,965
Long-term Liabilities  (as reported)17,965
Long-term Liabilities  (calculated)17,965
+/-0
Total Stockholder Equity
Common Stock6
Retained Earnings -121,924
Other Stockholders Equity 139,528
Total Stockholder Equity (as reported)17,610
Total Stockholder Equity (calculated)17,610
+/-0
Other
Capital Stock6
Cash and Short Term Investments 18,352
Common Stock Shares Outstanding 54,981
Liabilities and Stockholders Equity 41,561
Net Debt 961
Net Invested Capital 17,610
Net Working Capital 14,456
Property Plant and Equipment Gross 22,291
Short Long Term Debt Total 19,313



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-31
> Total Assets 
0
0
0
12,673
9,685
12,113
9,564
43,069
39,457
36,941
33,287
28,245
22,559
34,121
26,265
16,810
30,122
24,267
19,081
14,497
10,407
13,617
11,420
10,682
38,548
31,520
23,898
16,599
3,904
4,805
3,522
4,460
28,145
75,916
73,630
5,453
10,040
6,417
57,022
51,130
44,580
59,607
53,319
45,797
53,788
48,224
42,896
41,561
41,56142,89648,22453,78845,79753,31959,60744,58051,13057,0226,41710,0405,45373,63075,91628,1454,4603,5224,8053,90416,59923,89831,52038,54810,68211,42013,61710,40714,49719,08124,26730,12216,81026,26534,12122,55928,24533,28736,94139,45743,0699,56412,1139,68512,673000
   > Total Current Assets 
0
0
0
11,788
8,777
11,074
8,287
41,976
38,396
35,746
31,866
26,764
21,080
32,545
24,683
15,282
28,611
22,809
17,719
13,165
9,110
12,360
10,277
9,620
35,036
28,047
20,356
13,110
3,665
4,581
3,309
4,269
27,621
75,438
73,221
2,469
7,325
3,922
54,463
47,528
40,684
36,222
30,682
23,062
31,502
26,337
21,399
20,442
20,44221,39926,33731,50223,06230,68236,22240,68447,52854,4633,9227,3252,46973,22175,43827,6214,2693,3094,5813,66513,11020,35628,04735,0369,62010,27712,3609,11013,16517,71922,80928,61115,28224,68332,54521,08026,76431,86635,74638,39641,9768,28711,0748,77711,788000
       Cash And Cash Equivalents 
0
0
0
63
453
2,947
977
619
652
407
269
239
459
184
277
539
266
763
639
604
5,014
7,476
4,972
4,471
31,682
25,161
18,462
11,327
2,339
3,505
2,437
3,177
26,862
73,845
72,028
2,178
6,973
3,450
51,684
45,076
38,073
32,486
24,821
20,654
29,648
24,919
19,646
18,352
18,35219,64624,91929,64820,65424,82132,48638,07345,07651,6843,4506,9732,17872,02873,84526,8623,1772,4373,5052,33911,32718,46225,16131,6824,4714,9727,4765,0146046397632665392771844592392694076526199772,94745363000
       Short-term Investments 
0
0
0
8,612
4,131
3,080
697
34,000
29,087
26,180
21,400
15,721
9,786
23,691
17,546
10,336
23,625
17,366
12,705
7,235
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000007,23512,70517,36623,62510,33617,54623,6919,78615,72121,40026,18029,08734,0006973,0804,1318,612000
       Net Receivables 
0
0
0
469
595
459
746
708
1,295
1,209
1,308
1,501
822
677
447
274
782
926
668
1,831
475
718
1,194
504
597
629
264
455
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000004552646295975041,1947184751,8316689267822744476778221,5011,3081,2091,295708746459595469000
       Other Current Assets 
0
0
0
298
344
547
667
928
961
1,145
751
1,094
932
626
603
717
820
702
462
795
809
599
507
1,395
1,155
783
366
299
1,326
1,076
872
1,092
759
1,593
1,193
914
352
472
2,779
2,452
2,611
3,736
5,861
2,408
1,854
1,418
1,753
2,090
2,0901,7531,4181,8542,4085,8613,7362,6112,4522,7794723529141,1931,5937591,0928721,0761,3262993667831,1551,3955075998097954627028207176036269321,0947511,145961928667547344298000
   > Long-term Assets 
0
0
0
886
908
1,039
1,277
1,093
1,061
1,196
1,421
1,481
1,479
1,576
1,582
1,528
1,511
1,458
1,362
1,332
1,297
1,257
1,143
1,062
3,512
3,473
3,542
3,489
239
224
213
191
524
478
409
2,984
2,715
2,495
2,559
3,602
3,896
23,385
22,637
22,735
22,286
21,887
21,497
21,119
21,11921,49721,88722,28622,73522,63723,3853,8963,6022,5592,4952,7152,9844094785241912132242393,4893,5423,4733,5121,0621,1431,2571,2971,3321,3621,4581,5111,5281,5821,5761,4791,4811,4211,1961,0611,0931,2771,039908886000
       Property Plant Equipment 
0
0
0
723
738
860
957
1,005
1,001
1,138
1,351
1,432
1,429
1,525
1,527
1,489
1,466
1,414
1,327
1,299
1,258
1,191
1,114
1,025
3,471
3,447
3,524
3,464
232
212
193
174
505
446
387
2,784
2,515
2,295
2,300
1,961
2,259
21,759
21,184
21,345
20,901
20,511
20,027
19,650
19,65020,02720,51120,90121,34521,18421,7592,2591,9612,3002,2952,5152,7843874465051741932122323,4643,5243,4473,4711,0251,1141,1911,2581,2991,3271,4141,4661,4891,5271,5251,4291,4321,3511,1381,0011,005957860738723000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
200
200
259
0
1,637
0
0
0
0
0
0
0
00000001,6370259200200000000000000000000000000000000000000
> Total Liabilities 
0
0
0
21,894
24,091
26,578
29,086
8,451
8,998
8,840
8,783
7,982
6,623
6,032
5,666
5,662
5,757
5,464
6,109
6,615
6,876
7,073
7,528
7,598
10,019
10,325
9,612
9,324
5,222
2,722
2,980
5,132
7,139
3,812
4,021
2,988
11,158
11,233
5,662
6,822
6,212
27,213
27,112
25,036
25,078
24,400
24,564
23,951
23,95124,56424,40025,07825,03627,11227,2136,2126,8225,66211,23311,1582,9884,0213,8127,1395,1322,9802,7225,2229,3249,61210,32510,0197,5987,5287,0736,8766,6156,1095,4645,7575,6625,6666,0326,6237,9828,7838,8408,9988,45129,08626,57824,09121,894000
   > Total Current Liabilities 
0
0
0
2,683
2,894
3,389
3,898
8,451
8,998
8,840
8,783
7,982
6,623
6,032
5,666
5,662
5,757
5,464
6,109
6,615
6,876
7,073
7,528
7,598
7,433
7,838
7,185
6,959
5,222
2,722
2,980
5,132
6,940
3,661
3,919
2,086
2,541
2,905
5,620
6,822
5,863
7,086
7,433
5,723
6,138
5,784
6,270
5,986
5,9866,2705,7846,1385,7237,4337,0865,8636,8225,6202,9052,5412,0863,9193,6616,9405,1322,9802,7225,2226,9597,1857,8387,4337,5987,5287,0736,8766,6156,1095,4645,7575,6625,6666,0326,6237,9828,7838,8408,9988,4513,8983,3892,8942,683000
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
210
219
228
237
106
0
0
2,200
2,367
173
179
910
1,006
1,103
1,243
955
913
861
1,376
2,766
2,868
1,420
1,385
1,348
1,3481,3851,4202,8682,7661,3768619139551,2431,1031,0069101791732,3672,20000106237228219210000000000000000000000000
       Accounts payable 
0
0
0
314
498
701
432
513
414
330
544
710
707
671
694
1,156
895
558
826
752
1,611
1,220
1,546
1,305
1,600
1,255
1,126
1,093
1,588
517
285
486
1,607
670
758
281
473
644
1,969
1,177
746
1,989
1,891
542
570
645
815
817
8178156455705421,8911,9897461,1771,9696444732817586701,6074862855171,5881,0931,1261,2551,6001,3051,5461,2201,6117528265588951,156694671707710544330414513432701498314000
       Other Current Liabilities 
0
0
0
2,300
2,315
2,315
2,859
3,263
3,721
4,060
4,688
4,753
3,961
3,993
4,321
4,317
4,493
4,759
5,219
5,815
5,103
5,593
5,871
6,126
5,405
5,807
5,277
5,294
3,193
1,870
2,360
2,111
2,631
2,483
2,647
1,758
1,062
823
2,408
4,355
4,204
4,236
2,275
2,415
2,700
3,719
4,070
3,821
3,8214,0703,7192,7002,4152,2754,2364,2044,3552,4088231,0621,7582,6472,4832,6312,1112,3601,8703,1935,2945,2775,8075,4056,1265,8715,5935,1035,8155,2194,7594,4934,3174,3213,9933,9614,7534,6884,0603,7213,2632,8592,3152,3152,300000
   > Long-term Liabilities 
0
0
0
19,211
21,197
23,189
25,187
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,586
2,487
2,427
2,365
0
0
0
0
199
151
102
902
8,617
8,328
42
2,132
349
20,127
19,679
19,313
18,940
18,616
18,294
17,965
17,96518,29418,61618,94019,31319,67920,1273492,132428,3288,61790210215119900002,3652,4272,4872,5860000000000000000025,18723,18921,19719,211000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,000
8,000
0
0
0
0
0
0
0
0
0
0
00000000008,0008,000000000000000000000000000000000000000
> Total Stockholder Equity
0
0
0
-9,221
-14,406
-14,466
-19,522
34,618
30,459
28,101
24,504
20,263
15,936
28,089
20,599
11,148
24,365
18,803
12,972
7,882
3,531
6,544
3,892
3,084
28,529
21,195
14,286
7,275
-1,318
2,083
542
-672
21,006
72,104
69,609
2,465
-1,118
-4,816
51,360
44,308
38,368
32,394
26,207
20,761
28,710
23,824
18,332
17,610
17,61018,33223,82428,71020,76126,20732,39438,36844,30851,360-4,816-1,1182,46569,60972,10421,006-6725422,083-1,3187,27514,28621,19528,5293,0843,8926,5443,5317,88212,97218,80324,36511,14820,59928,08915,93620,26324,50428,10130,45934,618-19,522-14,466-14,406-9,221000
   Common Stock
0
0
0
88,311
89,049
96,659
98,540
163,171
163,441
165,470
165,642
166,049
166,435
186,618
186,618
186,769
200,416
200,867
200,867
202,156
206,163
216,805
221,774
229,019
263,418
263,656
263,656
264,008
264,003
270,126
270,126
270,126
294,592
347,940
347,940
54,649
54,650
54,662
109,050
109,050
109,050
5
5
5
5
6
6
6
6665555109,050109,050109,05054,66254,65054,649347,940347,940294,592270,126270,126270,126264,003264,008263,656263,656263,418229,019221,774216,805206,163202,156200,867200,867200,416186,769186,618186,618166,435166,049165,642165,470163,441163,17198,54096,65989,04988,311000
   Retained Earnings Total Equity000000-85,630-79,1040-65,50200000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
-267
-313
-344
-405
-474
-533
-477
-546
-581
-528
-558
-524
-608
-578
-486
-572
-572
-527
-604
-580
-575
-583
-574
-585
-562
-543
-533
-498
-448
-412
-387
-400
-379
-392
-424
-26
35
44
65
46
140
88
63
92
0
092638814046654435-26-424-392-379-400-387-412-448-498-533-543-562-585-574-583-575-580-604-527-572-572-486-578-608-524-558-528-581-546-477-533-474-405-344-313-267000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,838
0
8,378
117,954
0
0
0
0
0
0
000000117,9548,37807,83800000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
20,198
20,759
20,661
21,430
24,585
25,171
25,650
26,617
27,477
28,527
29,031
29,996
30,848
37,936
38,674
39,645
40,675
42,025
42,434
43,311
44,111
46,586
47,445
48,131
48,613
48,892
49,260
49,287
49,314
49,333
49,352
49,371
49,389
7,445
7,871
7,838
8,009
8,378
117,954
118,568
119,054
133,094
133,588
134,108
139,528
139,528134,108133,588133,094119,054118,568117,9548,3788,0097,8387,8717,44549,38949,37149,35249,33349,31449,28749,26048,89248,61348,13147,44546,58644,11143,31142,43442,02540,67539,64538,67437,93630,84829,99629,03128,52727,47726,61725,65025,17124,58521,43020,66120,75920,198000



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue0
Cost of Revenue-0
Gross Profit00
 
Operating Income (+$)
Gross Profit0
Operating Expense-24,677
Operating Income-24,677-24,677
 
Operating Expense (+$)
Research Development15,745
Selling General Administrative8,932
Selling And Marketing Expenses0
Operating Expense24,67724,677
 
Net Interest Income (+$)
Interest Income0
Interest Expense-0
Other Finance Cost-0
Net Interest Income0
 
Pretax Income (+$)
Operating Income-24,677
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-23,486-25,868
EBIT - interestExpense = 0
-46,972
-23,486
Interest Expense0
Earnings Before Interest and Taxes (EBIT)0-23,486
Earnings Before Interest and Taxes (EBITDA)-24,677
 
After tax Income (+$)
Income Before Tax-23,486
Tax Provision-0
Net Income From Continuing Ops-23,486-23,486
Net Income-23,486
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net1,1910
 

Technical Analysis of Vivani
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Vivani. The general trend of Vivani is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Vivani's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Vivani Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Vivani Medical Inc..

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 1.03 < 1.03 < 1.12.

The bearish price targets are: 0.9068 > 0.86 > 0.85.

Know someone who trades $VANI? Share this with them.πŸ‘‡

Vivani Medical Inc. Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Vivani Medical Inc.. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Vivani Medical Inc. Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Vivani Medical Inc..

Vivani Medical Inc. Daily Moving Average Convergence/Divergence (MACD) ChartVivani Medical Inc. Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Vivani Medical Inc.. The current adx is .

Vivani Medical Inc. Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Vivani Medical Inc..

Vivani Medical Inc. Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Vivani Medical Inc..

Vivani Medical Inc. Daily Relative Strength Index (RSI) ChartVivani Medical Inc. Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Vivani Medical Inc..

Vivani Medical Inc. Daily Stochastic Oscillator ChartVivani Medical Inc. Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Vivani Medical Inc..

Vivani Medical Inc. Daily Commodity Channel Index (CCI) ChartVivani Medical Inc. Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Vivani Medical Inc..

Vivani Medical Inc. Daily Chande Momentum Oscillator (CMO) ChartVivani Medical Inc. Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Vivani Medical Inc..

Vivani Medical Inc. Daily Williams %R ChartVivani Medical Inc. Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Vivani Medical Inc..

Vivani Medical Inc. Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Vivani Medical Inc..

Vivani Medical Inc. Daily Average True Range (ATR) ChartVivani Medical Inc. Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Vivani Medical Inc..

Vivani Medical Inc. Daily On-Balance Volume (OBV) ChartVivani Medical Inc. Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Vivani Medical Inc..

Vivani Medical Inc. Daily Money Flow Index (MFI) ChartVivani Medical Inc. Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Vivani Medical Inc..

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-11-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-11-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-11-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-02STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-12-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-12-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-10WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-17STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-30STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-12-31WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-01-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-01-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-01-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-01-23STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-01-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-01-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-01-31MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-02-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-02-04STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-02-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-02-13STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-02-18SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-02-19CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-02-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-24CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-02-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-02-27BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-03-03BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-07MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-10BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-11RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-12STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-13RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-18SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-19CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-03-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-31CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-04-04STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-07RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Vivani Medical Inc. Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Vivani Medical Inc. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose1.040
Total1/1 (100.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Vivani with someone you think should read this too:
  • Are you bullish or bearish on Vivani? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Vivani? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Vivani Medical Inc.

I send you an email if I find something interesting about Vivani Medical Inc..


Comments

How you think about this?

Leave a comment

Stay informed about Vivani Medical Inc..

Receive notifications about Vivani Medical Inc. in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.